1643 studies found for:    "Fibrin Modulating Agents"
Show Display Options
Rank Status Study
1 Recruiting Tranexamic Acid in Reverse Total Shoulder Arthroplasty
Conditions: Shoulder Joint Disease;   Complications; Arthroplasty;   Intraoperative Complications;   Blood Loss, Surgical
Intervention: Drug: Infusion Tranexamic acid or placebo.
2 Recruiting STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial
Conditions: Intracerebral Haemorrhage;   Stroke
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
3 Recruiting Clinical Efficacy of Tranexamic Acid and ε-Aminocaproic Acid in Reducing Blood Loss Following Total Knee Replacement
Condition: Osteoarthritis
Interventions: Drug: Tranexamic Acid (TXA);   Drug: ε-Aminocaproic Acid (EACA)
4 Active, not recruiting The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
Condition: Stroke, Acute
Interventions: Device: hypothermia;   Other: Group1: IV t-PA and normothermia
5 Completed
Has Results
Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
6 Completed
Has Results
A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters
Condition: Dysfunctional Hemodialysis Catheters
Interventions: Drug: placebo;   Drug: tenecteplase
7 Completed A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin
Conditions: Osteoarthritis;   Peptic Ulcer
Interventions: Drug: Lansoprazole and naproxen and aspirin;   Drug: Celecoxib and aspirin
8 Unknown  Efficacy and Safety of Adjunctive Cilostazol in Acute Myocardial Infarction Patients
Condition: Acute Myocardial Infarction
Intervention: Drug: antiplatelet therapy
9 Completed To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their Effects
Conditions: Pharmacodynamic and Pharmacokinetic Interaction;   Healthy Subjects
Interventions: Drug: Darexaban;   Drug: Acetyl Salicylic Acid (ASA)
10 Completed ReoPro and Retavase to Restore Brain Blood Flow After Stroke
Condition: Cerebrovascular Accident
Intervention: Drug: Abciximab (ReoPro) and Reteplase (Retavase)
11 Unknown  Incidence and Nature of Heparin-induced Skin Lesions in Medical Patients
Condition: Allergy
12 Completed Improving Aspirin Use Among Adults at Risk for Cardiovascular Disease (CVD)
Condition: Cardiovascular Disease
Interventions: Behavioral: Pre-visit Summary;   Behavioral: Clinical Decision Sharing Tool
13 Completed Determinants of Vitamin K Metabolism
Conditions: Aging;   Osteoporosis
Intervention: Drug: Vitamin K
14 Completed Evaluation of Antiplatelet Effects of Different Dosages of Aspirin in Type 2 Diabetic Patients
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Aspirin;   Drug: aspirin
15 Active, not recruiting Concentration of Antimicrobials in Catheter-lock Solutions
Conditions: Catheter-Related Infections;   Bacteremia.
Interventions: Drug: Vancomycin antimicrobial-lock solution;   Drug: Teicoplanin antimicrobial-lock solution;   Drug: Linezolid antimicrobial-lock solution;   Drug: Daptomycin antimicrobial-lock solution;   Drug: Tigecycline antimicrobial-lock solution
16 Terminated
Has Results
A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome
Condition: Suspected Heparin-Induced Thrombocytopenia
Intervention: Drug: Desirudin or Argatroban®
17 Not yet recruiting Aspirin and Enoxaparin for VTE in Trauma
Conditions: Venous Thromboembolism;   Thromboprophylaxis;   Trauma
Interventions: Drug: Aspirin;   Drug: Enoxaparin
18 Active, not recruiting PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Conditions: Brain Ischemia;   Intracranial Hemorrhages
Interventions: Drug: Cilostazol;   Drug: Probucol;   Drug: Aspirin;   Drug: placebo of cilostazol;   Drug: placebo of aspirin;   Device: ankle-brachial index (ABI);   Device: intima-medial thickness (IMT);   Device: new asymptomatic brain hemorrhage;   Device: new ischemic lesions on follow-up FLAIR images
19 Completed Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products
Condition: Pharmacodynamics
Interventions: Drug: Generic clopidogrel product Apolets®;   Drug: Original clopidogrel product Plavix®
20 Completed High Clopidogrel Dose Versus Prasugrel and Ticagrelor in High Reactive Stable Patients
Condition: Coronary Artery Disease
Interventions: Drug: Clopidogrel;   Drug: Prasugrel;   Drug: Ticagrelor

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years